Patents/Assignees

MEDIMMUNE LIMITED

35 patents in portfolio

US11779650utility2023
Pyrrolobenzodiazepine-antibody Conjugates
0 cites
US11771775utility2023
Pyrrolobenzodiazepine-antibody Conjugates
0 cites
US11773186utility2023
Antibodies to Ticagrelor and Methods of Use
0 cites
US11738081utility2023
Polynucleotides Encoding IL33 Antibodies and Methods of Using the Same
0 cites
US11701430utility2023
Pyrrolobenzodiazepines and Conjugates Thereof
0 cites
US11667698utility2023
Anti-rsv Monoclonal Antibody Formulation
0 cites
US11661449utility2023
Rsv-specific Antibodies and Functional Parts Thereof
0 cites
US11649250utility2023
Pyrrolobenzodiazepine Conjugates
0 cites
US11634483utility2023
Nucleic Acids Encoding Anti-vegf-a Antibodies and Uses Thereof
0 cites
US11612665utility2023
Pyrrolobenzodiazepine-antibody Conjugates
0 cites
US11613580utility2023
Anti-pad4 Autoantibodies as Clinical Response Biomarkers for the Treatment of Rheumatoid Arthritis
0 cites
US11596696utility2023
Combination Therapy with an Anti-cd25 Antibody-drug Conjugate
0 cites
US11591389utility2023
Nucleic Acids Encoding Anti-par2 Antibodies and Uses Thereof
0 cites
US11566068utility2023
Nucleic Acids Encoding Bispecific Anti-vegf and Anti-ang2 Antibodies and Uses Thereof
0 cites
US11560424utility2023
Antibodies to Alpha-synuclein and Uses Thereof
0 cites

← PreviousPage 2 of 2